BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24074562)

  • 21. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
    Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
    J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.
    Jeon SM; Chandel NS; Hay N
    Nature; 2012 May; 485(7400):661-5. PubMed ID: 22660331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer associated human papillomaviruses.
    McLaughlin-Drubin ME; Meyers J; Munger K
    Curr Opin Virol; 2012 Aug; 2(4):459-66. PubMed ID: 22658985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deregulated MYC expression induces dependence upon AMPK-related kinase 5.
    Liu L; Ulbrich J; Müller J; Wüstefeld T; Aeberhard L; Kress TR; Muthalagu N; Rycak L; Rudalska R; Moll R; Kempa S; Zender L; Eilers M; Murphy DJ
    Nature; 2012 Mar; 483(7391):608-12. PubMed ID: 22460906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.
    Namiki T; Tanemura A; Valencia JC; Coelho SG; Passeron T; Kawaguchi M; Vieira WD; Ishikawa M; Nishijima W; Izumo T; Kaneko Y; Katayama I; Yamaguchi Y; Yin L; Polley EC; Liu H; Kawakami Y; Eishi Y; Takahashi E; Yokozeki H; Hearing VJ
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6597-602. PubMed ID: 21460252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.
    Emmanuel C; Gava N; Kennedy C; Balleine RL; Sharma R; Wain G; Brand A; Hogg R; Etemadmoghadam D; George J; ; Birrer MJ; Clarke CL; Chenevix-Trench G; Bowtell DD; Harnett PR; deFazio A
    PLoS One; 2011 Mar; 6(3):e17617. PubMed ID: 21423607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
    Castro FA; Ivansson EL; Schmitt M; Juko-Pecirep I; Kjellberg L; Hildesheim A; Gyllensten UB; Pawlita M
    Int J Cancer; 2012 Jan; 130(2):349-55. PubMed ID: 21387292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
    Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
    Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV - immune response to infection and vaccination.
    Stanley M
    Infect Agent Cancer; 2010 Oct; 5():19. PubMed ID: 20961432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peutz-Jeghers syndrome: a systematic review and recommendations for management.
    Beggs AD; Latchford AR; Vasen HF; Moslein G; Alonso A; Aretz S; Bertario L; Blanco I; Bülow S; Burn J; Capella G; Colas C; Friedl W; Møller P; Hes FJ; Järvinen H; Mecklin JP; Nagengast FM; Parc Y; Phillips RK; Hyer W; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen JT; Clark SK; Hodgson SV
    Gut; 2010 Jul; 59(7):975-86. PubMed ID: 20581245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion.
    Zagórska A; Deak M; Campbell DG; Banerjee S; Hirano M; Aizawa S; Prescott AR; Alessi DR
    Sci Signal; 2010 Mar; 3(115):ra25. PubMed ID: 20354225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants and risk for HPV persistence and progression to cervical cancer.
    Wang SS; Gonzalez P; Yu K; Porras C; Li Q; Safaeian M; Rodriguez AC; Sherman ME; Bratti C; Schiffman M; Wacholder S; Burk RD; Herrero R; Chanock SJ; Hildesheim A
    PLoS One; 2010 Jan; 5(1):e8667. PubMed ID: 20084279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose deprivation-induced metabolic oxidative stress and cancer therapy.
    Simons AL; Mattson DM; Dornfeld K; Spitz DR
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1(Suppl 1):S2-6. PubMed ID: 20009288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1.
    Humbert N; Navaratnam N; Augert A; Da Costa M; Martien S; Wang J; Martinez D; Abbadie C; Carling D; de Launoit Y; Gil J; Bernard D
    EMBO J; 2010 Jan; 29(2):376-86. PubMed ID: 19927127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.
    Cheng H; Liu P; Wang ZC; Zou L; Santiago S; Garbitt V; Gjoerup OV; Iglehart JD; Miron A; Richardson AL; Hahn WC; Zhao JJ
    Sci Signal; 2009 Jul; 2(80):ra35. PubMed ID: 19622832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic LKB1 mutations promote cervical cancer progression.
    Wingo SN; Gallardo TD; Akbay EA; Liang MC; Contreras CM; Boren T; Shimamura T; Miller DS; Sharpless NE; Bardeesy N; Kwiatkowski DJ; Schorge JO; Wong KK; Castrillon DH
    PLoS One; 2009; 4(4):e5137. PubMed ID: 19340305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.
    Zheng B; Jeong JH; Asara JM; Yuan YY; Granter SR; Chin L; Cantley LC
    Mol Cell; 2009 Jan; 33(2):237-47. PubMed ID: 19187764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.
    Ralser M; Wamelink MM; Struys EA; Joppich C; Krobitsch S; Jakobs C; Lehrach H
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17807-11. PubMed ID: 19004802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.